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Tests for 2 × 2 Tables in Clinical Trials
Vic Hasselblad

Yuliya Lokhnygina

Duke University

Five standard tests are compared: chi-squared, Fisher's exact, Yates’ correction, Fisher’s exact mid-p, and
Barnard’s. Yates’ is always inferior to Fisher’s exact. Fisher’s exact is so conservative that one should
look for alternatives. For certain sample sizes, Fisher’s mid-p or Barnard’s test maintain the nominal
alpha and have superior power.
Key words: Power, sample size, dichotomous endpoint, alpha level
methyl ester (L-NAME) to placebo in patients
with cardiogenic shock. Mortality results are
given in Table 1.
Cotter et al. reported a p-value of 0.028
(no test specified), a value which is consistent
with the standard chi-square test. However, if
Fisher’s exact test had been used in the standard
manner, the p-value would have been 0.0656. If
Fisher’s mid-p or Barnard’s test had been used,
then the p-value would have been 0.0374 or
0.0352, respectively. The results of this trial,
along with other preliminary data, were
suggestive of an effect, and so a second study,
SHOCK II (Dzavik et al., submitted), was
conducted. Ironically, the SHOCK II Trial
showed no evidence of a treatment effect, but
there were significant differences between the
SHOCK II Trial and the Cotter Trial.
The second example is taken from the A
to Z Trial (Blazing et al., 2004). This trial
compared enoxaparin with un-fractionated
heparin for the treatment of 3905 patients with
acute coronary syndrome (ACS). Based on other
studies, there was a concern that enoxaparin
might lead to an increase in the number of
bleeding events. Given in Table 2 are the counts
of patients with TIMI major bleeding events by
treatment arm.
Note that the bleeding rates are quite
low in both arms (less than one percent). The
Statistical Analysis Plan specified that
“Statistical comparison will be conducted using
Fisher’s exact test …”

Introduction
The literature on tests for 2×2 tables is
extremely vast and controversial. However, the
issues can be focused somewhat when
considering the use of these tests for clinical
trials. In this situation, the trials have two arms
and the sample size of each arm is fixed. Tests
are almost always made at the 0.05 nominal
alpha level. There is no requirement that the
tests be computationally simple, but only that
they are available in standard commercial
statistical software. The following two examples
illustrate many of the issues of interest.
Cotter et al (2000) conducted a small,
randomized pilot study (15 patients per
treatment arm) comparing Nω-nitro-L-arginine
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Table 1. Deaths by Treatment Arm in the L-NAME Trial
L-NAME

No L-NAME

Total

4

10

14

Survived

11

5

16

Total

15

15

30

Died

Table 2. Bleeding Events by Treatment Arm for the A to Z Trial
Enoxaparin

Un-fractionated

Total

Heparin
Bleed

18

8

26

No bleed

1922

1957

3879

Total

1940

1965

3905

In this case, Fisher’s exact test gives a pvalue between 0.0285 and 0.0501. The problem
with Fisher’s exact test is that it is .0393 or
0.0352, respectively. It is clear that summarizing
the results of the above table as non-significant
would not accurately describe the information.
These two examples point out some of
the difficulties in choosing a statistical test in the
simplest of trials, namely the two-arm
dichotomous trials. There are several possible
tests that can be used and they have different
implications for both the nominal alpha level as
well as the power. We will restrict our
consideration to those tests available in
commercial software packages such as SAS®

(SAS Institute, 1999) or StatXact (StatXAct
with Cytel Studio, 2005).
Methodology
Assume a study where the number of positives
and negatives are measured for a control group
and a treated group, and that the results are
summarized in a standard 2 x 2 contingency
table where A, B, C, and D are the observed
counts. Let T = A + B + C + D. The rate in the
treated group, p1, is estimated by A / N1 and the
rate in the control group, p2, is estimated by C /
N2. The null hypothesis is that p1 = p2 and the
usual alternative hypothesis is
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Treated

Control

Total

Positive

A

C

S1

Negative

B

D

S2

Total

N1

N2

T

that p1 ≠ p2. The object is to find a test statistic
which is a function of A, B, C, and D such that
the value of the test is very different when p1 =
p2 as compared with when p1 ≠ p2. There are
several test statistics which could be used to test
the null hypothesis, and the properties of five
such tests will be investigated: 1) the
uncorrected chi-squared test, 2) Fisher's exact
test, 3) Yates’ correction to the chi-squared test,
4) Fisher’s exact mid-p test, and 5) Barnard’s
test.
Uncorrected chi-squared test
The standard uncorrected chi-squared
statistic (Pearson, 1900) is:
2

CS =

T(AD - BC )
N1N 2S1S 2

.

(1)

For an intended α-level of 0.05, the test rejects
the null hypothesis whenever CS > 3.8415 and
accepts otherwise. The power of the test is the
probability that CS > 3.8415 given particular
values of p1, p2, N1, and N2.
Fisher’s exact test
In 1925, Fisher (1925) gave an exact test
which requires a bit more effort to compute. The
test is based on the hyper geometric distribution.
Assume that the four marginal totals, N1, N2, S1,
and S2, are fixed. Under the null hypothesis, the
probability that A = i for i = 0, 1,… , min(N1, S1)
is:

Prob(A N1 , N2 , S1 , S2 ) =
⎛ S1 ⎞ ⎛ S2 ⎞
⎜ ⎟⎜N − A⎟
⎝ A ⎠⎝ 1
⎠

⎛T ⎞
⎜ ⎟.
⎝ N1 ⎠

(2)

The (two sided) probability of an observed or
more extreme than observed result is given by

∑

Pr ob(i N1,N2 ,S1,S2 )

Pr ob(i N1,N2 ,S1 ,S2 ) < Pr ob( A N1,N2 ,S1,S2 )

+ Pr ob(A N1,N2 ,S1,S2 )

(3)

For example, the values for Cotter et al (2000)
are 0.0092 + 0.0564 = 0.0656. The two values,
0.0092 and 0.0656, are the only two reasonable
values for the size of Fisher’s exact test in this
particular case (see Kendall and Stuart, Vol. 2,
pp. 553, 1961). A non-randomized test cannot be
constructed at any arbitrary level. But by
convention, the largest value, 0.0656, is often
taken as the p-value from the test. This value is
often described as conservative, but it is only
conservative if the object is to reject the null
hypothesis. Thus, the null hypothesis would not
be rejected at the 0.05 level using this test in this
particular manner. The test could be made exact
by choosing a random number between the
values of 0.0092 and 0.0656 as the p-value.
However, using randomization as part of the
hypothesis testing procedure has never been
accepted in clinical literature. This example
demonstrates that using a conservative test is not
necessarily a conservative strategy when the
endpoint in question is a safety endpoint.

Yates’ corrected chi-square test
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The third test is Yates’ (1934) correction
to the Pearson chi-squared statistic:

CSC =

T(| AD - BC | -T/2)2
N1N2S1S 2

.

(4)

This correction is designed to make the chisquared statistic give a p-value which is often
very close to the p-values calculated from
Fisher's exact test.
Fisher’s mid-p test
The fourth test is a modification of
Fisher’s exact test, known as Fisher’s mid-p
value, as defined by Lancaster (1961). The
calculations are made exactly as those done for
Fisher’s exact test, except that the probability of
a result more extreme is averaged with the
probability of a result as extreme or more so. In
the Cotter et al. (2000) example, this would be
(0.0092 + 0.0656)/2 = 0.0374. StatXact (2005)
and LogXact (LogXact with Cytel Studio, 2005)
report mid-p values as part of their output.
Barnard’s test
Barnard
(1947)
proposed
an
unconditional exact test based on a minimax
elimination of the nuisance parameter. The
reference set was defined to be the set of all 2 x
2 tables with fixed row margins and all possible
column margins. Because the reference set for
Barnard’s test does not fix the column margins,
the distribution of the test statistic is less discrete
than would be obtained by permuting the
conditional reference set in which both margins
are fixed. However, Barnard was not satisfied
with his test, and disavowed it two years later
(Barnard, 1949). There is an interesting
discussion by Barnard of the reasons for his
disavowal in Yates (1984, with discussion).
Barnard invoked Fisher’s principle of ancillarity
(see Fisher, 1973, Chapter IV), whereby
inference should be based on hypothetical
repetitions of the original experiment, fixing
those aspects of the experiment that are
unrelated to the hypothesis under test. Little
(1989) gives a clear discussion of this topic. In
two more recent publications, Barnard (1989,
1990) provided additional arguments against the

test. However, Little (1989) showed that the row
totals are not ancillary statistics.
If the true value of p was known under
the null hypothesis (p1 = p2 = p), then the
probability of any possible outcome could be
calculated, e.g. the probability of x1 events in the
first arm (of size N1), and x2 events in the second
arm (of size N2):
Pr( x1, x 2 ) =

⎛ N1 ⎞ X1
N1 − x1
⎜ ⎟ p (1− p )
⎝ x1 ⎠
⎛ N2 ⎞ X2
N2 − x2
⎜ ⎟ p (1− p )
⎝ x2 ⎠

(5)

Next, order the outcomes. One possible ordering
would be to use the D statistic:

D=

x2 x1
−
N2 N1

(6)

⎛ x1 + x2 ⎞ ⎛ N1 + N2 − x1 − x2 ⎞ ⎛ 1 1 ⎞
⎜
⎟⎜
⎟⎜ +
⎟
N1 + N2
⎝ N1 + N2 ⎠ ⎝
⎠ ⎝ N1 N2 ⎠

Using this ordering, the probabilities can be
found of all tables at least as extreme, or more
so, than the observed table for a given p. The
sum of all these probabilities is the p-value
associated with the specified p. Calculate this pvalue for all possible specified p’s and take their
maximum. This is Barnard’s p-value. A plot of
the extreme values as a function of p for the
Cotter et al (2000) example is in Figure 1.
Note that the statistic reaches a
maximum of 0.0352, and this is Barnard’s pvalue for the Cotter et al study (2000). Barnard’s
test is actually guaranteed to be conservative for
certain specific sample sizes. The reason that the
test is not always conservative is that it uses a
normal approximation to order the outcomes.
Power Formulas
The formula for the probability of
rejection for any test of equality of proportions
is given by:
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Figure 1. Calculation of Barnard’s Statistic for Specified Null Probabilities (p1)
P r[ re je c t ] =
N1

N2

∑ ∑δ
i =0 j =0

i j

⎛ N1 ⎞⎛ N2 ⎞ i
N1 − i
N −j
p2j (1 − p2 ) 2
⎜ ⎟⎜ ⎟ p1 (1 − p1 )
⎝ i ⎠⎝ j ⎠

(7)

where N1 and N2 are the sample sizes of the two
arms respectively, where p1 and p2 are the true
event rates in each arm, and where δi j is one if
the test statistic based on i, N1, j, N2 is
statistically significant, and zero otherwise.
This formula can be used to determine
either the nominal alpha level for a given test
(by assuming that p1 equals p2) or to determine
the power (by not assuming equality). The
formula is an exact one – no simulations are
necessary. All results presented in the next
section are exact calculations.
Results
The actual alpha-levels are calculated for all five
tests assuming that the intended alpha-level was
0.05 and N1 = N2 = 25, N1 = N2 = 50, N1 = N2 =

100, and N1 = 25, N2 = 50. The calculations
were made for the entire range of p1 (with p2=
p1) and these are shown in Figures 2, 3, 4 and 5.
Note that the actual alpha-levels for the
standard chi-square, Fisher’s mid-p, and
Barnard’s tests are reasonably close to the
intended alpha-level for 0.2 < p1 < 0.8. The
maximum actual alpha-level for any test never
exceeds .065 for any p1. Note also that Fisher's
exact test has very low alpha-levels. The
maximum alpha-level for Fisher's exact test for
N1 = N2 = 25 is 0.0328. Yates’ correction to the
standard chi-square test yields alpha levels as
low as or lower than Fisher’s exact test. Fisher’s
mid-p test falls below the nominal alpha level of
0.05 everywhere, but is uniformly larger than
either Fisher’s exact or Yates’ correction.
Barnard’s test is as large, or larger, than Fisher’s
mid-p, but it does exceed 0.05 for event rates
between 0.107 and 0.172 and between 0.828 and
0.893.
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Figure 2. Alpha Levels for Two Arm Dichotomous Tests for N1 = N2 = 25
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Figure 3. Alpha Levels for Two Arm Dichotomous Tests for N1 = N2 = 50

462

TESTS FOR 2X2 TABLES IN CLINICAL TRIALS
0.10

0.09

0.08

Alpha Level

0.07

0.06

0.05

0.04

0.03

0.02

0.01

0.00
0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

P1 (=P2)

Chi-square

Fisher's Exact

Fisher's Mid-P

Barnard's Test

Yates' Correction

Figure 4. Alpha Levels for Two Arm Dichotomous Tests for N1 = 100, N2 = 100
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Figure 5. Alpha Levels for Two Arm Dichotomous Tests for N1 = 25, N2 = 50
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Alpha > 0.050

Figure 6. Diagram of Maximum Alpha Levels for Fisher’s Mid-P Test
with Nominal Alpha Level of 0.05.
For sample sizes of 50 per arm, the
actual alpha-levels for the standard chi-square,
Fisher’s mid-p, and Barnard’s tests approach the
nominal alpha-level for 0.2 < p1 < 0.8. The
maximum actual alpha-level for any test never
exceeds .057 for any p1. Fisher's exact test still
has very low alpha-levels, falling below 0.035
everywhere. Fisher’s mid-p test remains below
the nominal alpha level of 0.05 for event rates
below 0.3, but does reach a maximum of 0.057.
Barnard’s test never exceeds 0.0507, and is
generally closer to 0.05 than any of the other
tests.

For sample sizes of 100 per arm, the actual
alpha-levels for the standard chi-square, Fisher’s
mid-p, and Barnard’s tests approach the nominal
alpha-level for 0.1 < p1 < 0.9. The maximum
actual alpha-level for any test never exceeds
.056 for any p1. Fisher's exact test is increased,
but still falls below 0.040 everywhere. Fisher’s
mid-p test falls below the nominal alpha level of
0.05 for event rates below 0.3, but does reach a
maximum of 0.056. Barnard’s test never exceeds
0.053, and is generally closer to 0.05 than any of
the other tests.
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Figure 7. Diagram of Maximum Alpha Levels for Barnard’s Test
with Nominal Alpha Level of 0.05.

Fisher’s exact test had alpha levels a bit
closer to that of the other tests, but Yates’
correction had very low alpha levels, achieving a
maximum of 0.0270.
For unequal samples of 25 and 50 per
arm, the results were somewhat similar to the
previous results. Barnard’s test had a maximum
alpha level of 0.0484 and Fisher’s mid-p test had
a maximum alpha level of 0.0503. However, the
chi-square test had a maximum of 0.0599.
The results from Figures 2 – 5 are
consistent with the results presented by
Hasselblad and Allen (2003). Their results

suggested that an expected number of events of
approximately 40 is required to insure that the
actual alpha level for the chi-square test is
between 0.049 and 0.051 when the intended
alpha level is 0.05.
Fisher’s mid-p and Barnard’s tests are
examined in greater detail. Specifically, the
interest is to determine if those tests were
conservative for all values of p1 (with p2= p1) for
specific values of N1 and N2. The results for
Fisher’s mid-p for N1 = 10, … ,40 and N2 = 10,
… ,40 are in Figure 6. Those squares which are
white correspond to an actual alpha level less
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Figure 8. Power of Various Tests for Sample Sizes of 25 Per Arm
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Figure 10. Estimated Power Using Approximation versus Actual Power of the Chi-square Test
for Sample Sizes of 25 in the Control Arm and 50 in the Treated Arm

than 0.05 for all p.
For example, if one sample size is 15
and the other is 15, 16,…, or 25, then Fisher’s
mid-p test is conservative. On the other hand, if
both sample sizes are 26, then the test may not
be conservative, depending on the true null rate.
However, for most null rates, the test will still be
conservative. Figure 6 only shows the worst
possible case. Of the 496 different sample size
combinations shown in Figure 6, 40.9 percent
had a nominal alpha level less than 0.05.
The results for Barnard’s test for N1 =
10, … ,40 and N2 = 10, … ,40 are in Figure 7.
For example, if one sample size is 25 and the
other is 18, 19,…, or 24, then Barnard’s test is
conservative. On the other hand, if both sample
sizes are 25, then the test may not be
conservative, depending on the true null rate. Of
the 496 different sample size combinations
shown in Figure 7, 66.5 percent had a nominal
alpha level less than 0.05.
The power for four of the tests described
previously was calculated for N1 = N2 = 25 and
p1 = 0.3 (Yates’ test was dropped to make the

graph more readable). The results are in
Figure 8.
Note that the power curves behave as
expected, that is, they reach a minimum at p1 =
p2 = 0.3 and then increase rapidly as p2 moves
away from p1. The shapes of the power curves
are all quite similar. The differences at p1 = p2 =
0.3 are exactly the differences in the alpha-levels
of the tests. The power curves show one other
key point – the tests do not cross each other.
That is, if a test has a lower nominal alpha level,
then it will have lower power for the
alternatives.
The power for four of the tests was also
calculated for N1 = 25, N2 = 50 and p1 = 0.5. The
results are in Figure 9.
Figure 9 shows the same general
patterns as did Figure 8.
There are approximate formulas for
power that are reasonably accurate.
One
formula given by Fleiss (1981, p. 27) is
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β=
⎛⎛
⎞
1 ⎞
⎛1
Φ ⎜ ⎜ cα / 2 p (1 − p ) ⎜ +
⎟ - ( p 2 - p1 ) ⎟⎟
⎜⎜
N
N
⎝
1
2⎠
⎠
⎝⎝

p1 (1 − p1 )
N1

+

p 2 (1 − p2 ) ⎞
⎟
⎟
N2
⎠

where p = (p1 + p2)/2 and Φ is the cumulative
normal distribution function. This approximate
function is shown in Figure 10, where it is
drawn as a function of p2. The exact and
approximate formulas are reasonably similar,
and they get closer as the sample size increases.
There are several other formulas that have
various correction formulas in order to make the
approximation better. There is, however, a limit
to the accuracy of these approximations because
they are not based on the test statistic itself.
Conclusion
There are some conclusions which can be made
as a result of the calculations presented:
•

Even though Fleiss (1981, p. 27) states
that “[Yates’] correction should always
be used”, the test is always inferior to
(its nominal alpha level is less than or
equal to) Fisher’s exact test, and for that
reason it should not be used.

•

Fisher’s exact test is so conservative that
one should always look for an
alternative even if one requires that the
alpha level of the test not exceed the
nominal level (by even the smallest
amount). For certain sample sizes, either
Fisher’s mid-p or Barnard’s test will
satisfy the requirement, and those tests
have much superior power. For
example, knowing that the test is
conservative when both arms have 15
observations, the data of Cotter et al.
(2000) could have been analyzed using
Fisher’s mid-p test.

•

A to Z bleeding data is 0.05007
(assuming that the true event rates are
less than 20 percent).

(8)

For tests of safety, being conservative is
not desirable. Because event rates are
often very low for safety issues, Fisher’s
mid-p test is a very appealing
alternative. For example, the maximal
nominal alpha level for this test for the

•

The chi-square test works adequately for
very large sample sizes, but the standard
rule of an expected minimum value of 5
(which is commonly used) is not
acceptable. Even if the expected number
of counts exceeds 40 per cell, the alpha
level (for a nominal alpha level of 0.05)
is approximately bounded by 0.049 and
0.051. Barnard’s test is certainly an
attractive alternative in the moderate
sample size situation when the event
rates are not especially small.

As mentioned previously, only tests
available in widely used commercial software
packages were considered. Such restrictions
leave out some recently developed unconditional
tests for which no commercially developed and
tested software is available. An example is a test
based on the confidence interval p-value
developed by Berger and Boos (1994, 1996).
This test can be seen as a modification of
Barnard’s test. Although Barnard’s p-value is
obtained by maximizing the p-value for given
nuisance parameter p over the unit interval, the
p-value of the test by Berger and Boos is
obtained as a sum of the supremum of p-values
over the 100(1-β)% confidence interval for p
calculated from the data and β. This test can be
more powerful then Barnard’s and requires less
computational effort.
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